Potent inhibitors of the MAP kinase p38

James R. Henry, Kenneth C. Rupert, John H. Dodd, Ignatius J. Turchi, Scott A. Wadsworth, Druie E. Cavender, Peter H. Schafer, John J. Siekierka

Research output: Contribution to journalArticle

45 Scopus citations

Abstract

The MAP kinase p38 plays a key role in the biosynthesis of the inflammatory cytokines TNF-α and IL-1. We have developed a novel series of potent p38 inhibitors that could lead to new methods of treatment for inflammatory diseases such as rheumatoid arthritis and inflammatory bowel disease.

Original languageEnglish
Pages (from-to)3335-3340
Number of pages6
JournalBioorganic and Medicinal Chemistry Letters
Volume8
Issue number23
DOIs
StatePublished - 1 Dec 1998

    Fingerprint

Cite this

Henry, J. R., Rupert, K. C., Dodd, J. H., Turchi, I. J., Wadsworth, S. A., Cavender, D. E., Schafer, P. H., & Siekierka, J. J. (1998). Potent inhibitors of the MAP kinase p38. Bioorganic and Medicinal Chemistry Letters, 8(23), 3335-3340. https://doi.org/10.1016/S0960-894X(98)00589-7